Mesonephric-like adenocarcinoma of the uterine corpus: a case report - Scorecard - MDSpire

Mesonephric-like adenocarcinoma of the uterine corpus: a case report

  • By

  • Ting Wang

  • Wenlin Yang

  • Xianglun Gong

  • Bing Xue

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: A Case Study of Mesonephric-like Adenocarcinoma in the Uterine Corpus

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPostmenopausal women, particularly those aged 50 and above presenting with irregular vaginal bleeding.
Care Setting

Key Highlights

  • Remove 'Long-term follow-up is crucial due to potential for recurrence.'

Guideline-Based Recommendations

Diagnosis

    Management

    • Surgical resection remains the primary treatment; adjuvant chemotherapy with carboplatin and paclitaxel is commonly used but not universally established.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Combination chemotherapy is commonly used post-operatively, though no universally established standard exists.

        Clinical Best Practices

        • Specify conditions to differentiate from when discussing misdiagnosis potential.

        Related Resources & Content

        Original Source(s)

        Related Content